Ignite Creation Date:
2024-05-06 @ 6:39 PM
Last Modification Date:
2024-10-26 @ 2:52 PM
Study NCT ID:
NCT05735184
Status:
RECRUITING
Last Update Posted:
2024-05-16
First Post:
2023-02-09
Brief Title:
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With VenetoclaxAzacitidine Venetoclax or 73 in Patients With AML
Sponsor:
Kura Oncology Inc
Organization:
Kura Oncology Inc
Organization Data
Organization:
Kura Oncology Inc
Class:
INDUSTRY
Study ID:
KO-MEN-007
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Kura Oncology Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None